Healius is a diagnostics & research business based in Australia. Healius shares (HLS) are listed on the Australian Securities Exchange (ASX) and all prices are in Australian dollars. Healius has a trailing 12-month revenue of around $1.7 billion. If you're looking to buy shares, check out the steps below.
To buy shares listed in Australia such as Healius, you'll need to sign up to a broker with access to the ASX. Our table can help you compare share trading platforms and choose. Then follow these steps.
Our top pick for
Best for beginner
Our top pick for
Education & learning
Our top pick for
Australian stocks
| 52-week range | $1.09 - $3.022 |
|---|---|
| 50-day moving average | $1.2806 |
| 200-day moving average | $1.7685 |
| Target price | $1.25 |
| PE ratio | N/A |
| Dividend yield | N/A (0%) |
| Earnings per share (TTM) | $-1.65 |
The technical analysis gauge below displays real-time ratings for the timeframes you select. However, this is not a recommendation. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.
Historical closes compared with the last close of A$1.25
| 1 week (2024-04-18) | 3.31% |
|---|---|
| 1 month (2024-03-26) | -1.96% |
| 3 months (2024-01-25) | -11.03% |
| 6 months (2023-10-26) | -35.23% |
| 1 year (2023-04-26) | -58.33% |
|---|---|
| 2 years (2022-04-26) | -72.59% |
| 3 years (2021-04-26) | -69.88% |
| 5 years (2019-04-26) | -59.02% |
Valuing Healius stock is incredibly difficult, and any metric has to be viewed as part of a bigger picture of Healius's overall performance. However, analysts commonly use some key metrics to help gauge the value of a stock.
Healius's EBITDA (earnings before interest, taxes, depreciation and amortisation) is $107.2 million (£0.0 million).
The EBITDA is a measure of a Healius's overall financial performance and is widely used to measure stock profitability.
| Revenue TTM | $1.7 billion |
|---|---|
| Operating margin TTM | 1.85% |
| Gross profit TTM | $554.3 million |
| Return on assets TTM | 1.31% |
| Return on equity TTM | -68.02% |
| Profit margin | -57.63% |
| Book value | 1.447 |
| Market capitalisation | $907.6 million |
TTM: trailing 12 months
We're not expecting Healius to pay a dividend over the next 12 months.
Healius's shares were split on a 511:493 basis on 21 August 2018. So if you had owned 493 shares the day before the split, the next day you would own 511 shares. This wouldn't directly have changed the overall worth of your Healius shares – just the quantity. However, indirectly, the new 3.5% lower share price could have impacted the market appetite for Healius shares which in turn could have impacted Healius's share price.
Over the last 12 months, Healius's shares have ranged in value from as little as $1.09 up to $3.022. A popular way to gauge a stock's volatility is its "beta".
Beta measures a share's volatility in relation to the market. The market (AU average) beta is 1, while Healius's is 0.654. This would suggest that Healius's shares are less volatile than average (for this exchange).
Healius Limited provides specialty diagnostic services to consumer and practitioners in Australia. The company operates through three segments: Pathology, Imaging, and Others. It offers diagnostic imaging services, private medical laboratory, and pathology services. It also provides cataract surgery, colonoscopy, gastroscopy, plastic and cosmetic surgery, skin cancer removal, IVF egg collection, and gynaecological surgery services under the Laverty Pathology, Dorevitch Pathology, QML Pathology, Western Diagnostic Pathology, Genomic Diagnostic, Vetpath Laboratory, Vetnostics, QML Vetnostics, TML Vetnostics, ASAP Laboratory, Abbott Pathology, TML Pathology, IQ, Pathology, Kossard, Gastrolab, and Agilex Biolabs; Lumus Imaging; and Montserrat brands. The company was formerly known as Primary Health Care Limited and changed its name to Healius Limited in December 2018. Healius Limited was incorporated in 1994 and is based in Sydney, Australia.
AMP Ltd Preferred
AUD105.00
ANZ Group Holdings Ltd. Pfd.
AUD103.03
Challenger Ltd Preferred
AUD105.96
Macquarie Bank Ltd Pref
AUD105.81
Macquarie Group Ltd Pref C
AUD102.77
Macquarie Group Ltd Pref
AUD105.55
Macquarie Group Limited
AUD106.07
Suncorp Group Ltd Pref
AUD100.82
Westpac Banking Corp Pref
AUD102.91
Everything we know about the Sun Silver IPO, plus information on how to buy in.
Everything we know about the Tasmea Limited IPO, plus information on how to buy in.
Steps to owning and managing Far Northern Resources shares.
Commodity ETFs can be used to hedge against inflation. Here's what they do, why they should be on your watchlist and how they can help your portfolio.
Looking for the best performing stocks in Australia? We update this list weekly.
Steps to owning and managing Gol Linhas Aéreas Inteligentes SA shares from Australia.
Trade ASX stocks and ETFs with a $2 brokerage fee and a low minimum investment of just $10.
These ETFs have the lowest fees on the market, but does that make them the best?
You've heard of CommSec but how does it stack up to the likes of IG, CMC Invest and other players in the market?
Westpac Share Trading allows you to take control of your investments. Find out if its right for you.